Integration of GLP-1 Receptor Agonists into Comprehensive Cardiometabolic Care GLP-1 receptor agonists are increasingly transitioning from glucose-lowering therapies to comprehensive cardiometabolic treatment options due to expanding clinical evidence supporting cardiovascular, renal, and weight management benefits
The needle was left in the places for 30 s to avoid dye leakage into the peritoneal cavity
As NAc is also an important brain region associated with GLP-1-induced feeding suppression, further electrophysiological studies are necessary to explore the contribution of glutamatergic neurotransmission to endogenously released GLP-1-induced suppression of high-fat food intake in the VTA
Although more data is needed from RCTs and there are indeed cost challenges, the GLP-1RAs have, in my opinion, significant potential clinical implications in treatment of other disease states as well
Otros reportan cambios en las preferencias alimentarias, evitando ciertos grupos de alimentos que previamente contribuan a su ingesta de electrolitos